Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, ...

ORLANDO -- New results from the randomized CAHtalyst trials shed light on the benefits of crinecerfont (Crenessity) for adult and pediatric patients with congenital adrenal hyperplasia (CAH), a rare ...

Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 ...

An open-label study of 12 individuals with severe treatment-resistant depression found that their symptoms significantly ...

The clinical, cardiovascular and neuroendocrine profile of ampreloxetine showed target engagement of residual peripheral autonomic neurons and a sustained standing blood pressure effect, which is ...

Both coffee and matcha are high in caffeine and antioxidants. While coffee gives you an instant energy kick, matcha offers a ...

Chemomab Therapeutics Ltd.(Nasdaq:CMMB), (Chemomab), a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced ...

Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

Mineralys Therapeutics, Inc. ( NASDAQ: MLYS) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET ...